Last reviewed · How we verify
NCT04101188
Mechanisms Underlying the Protective Vascular Effects of Dietary Potassium in Humans
NA trial testing Moderate Potassium/Low Sodium Diet in Cardiovascular Risk Factor in 90 participants. Currently enrolling.
31 July 2026
Quick facts
| Lead sponsor | University of Delaware |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 90 |
| Start date | 16 January 2020 |
| Primary completion | 31 July 2026 |
| Estimated completion | 31 July 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Moderate Potassium/Low Sodium Diet
- Moderate Potassium/High Sodium Diet
- High Potassium/High Sodium Diet
Conditions studied
- Cardiovascular Risk Factor — all drugs for Cardiovascular Risk Factor →
Sponsor
University of Delaware
Who can join
Adults 18 to 45, any sex, with Cardiovascular Risk Factor. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Americans continue to consume high amounts of sodium. Potassium is notable for its blood pressure lowering effects but less is known regarding its effect on the vasculature. This investigation seeks to determine the role of dietary potassium on the vasculature in the presence of a high sodium diet in salt-resistant adults.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04101188
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Moderate Potassium/Low Sodium Diet
Trials testing the same drug.
- NCT03265353 — Vascular Effects of Dietary Potassium · NA · completed
Other recruiting trials for Cardiovascular Risk Factor
Currently open trials in the same condition.
- NCT07268781 — Impact of Golden Rice-Piper Crocatum Cookies on Lipid Control in Diabetes Mellitus Patients · NA · active not recruiting
- NCT06225544 — Lumasiran in Hyperoxalaemic Patients on Haemodialysis · Phase 2 · recruiting
- NCT06372054 — TORNADO-Omics Techniques and Neural Networks for the Development of Predictive Risk Models · recruiting
- NCT05887622 — The Potassium Supplementation Study · NA · recruiting
- NCT04950218 — Prevalence and Risk Factors asSOciated With CArdiac comorbiDIty in psoriAsis · recruiting
Other University of Delaware trials
Trials by the same sponsor.
- NCT07420218 — Menopausal Hormones and Sympathetic Activation · Phase 4 · not yet recruiting
- NCT07536217 — Developmental Pilot of Support Groups for Caregivers of Children With DLD · NA · enrolling by invitation
- NCT07054840 — Pain and Split-belt Motor Learning in Older Adults · NA · recruiting
- NCT06916260 — Light Therapy Intervention in Individuals With Parkinson's Disease · NA · recruiting
- NCT07071077 — Examining the Feasibility of Implementing a Hypertension Storytelling Intervention Among African Americans · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04101188 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Delaware
- Last refreshed: 4 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04101188.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing